RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/30512185http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/30512185http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/30512185http://www.w3.org/2000/01/rdf-schema#comment"NK cells kill cancer cells and infected cells upon activation by cell surface receptors. Human NKp30 is an activating receptor expressed by all mature NK cells. The B7 family member B7H6 has been identified as one ligand for NKp30. Several alternative ligands have also been reported, and the field remains unsettled. To this end, we have identified full-length functional B7H6 orthologs in rat and cattle, demonstrated by phylogenetic analysis and transfection experiments. In cell-cell contact-dependent assays, chimeric NKp30 reporter cells responded strongly to B7H6 in rat and cattle. Likewise, rat NKp30 expressing target cells induced strong activation of B7H6 reporter cells. Together, these observations demonstrate that B7H6 is conserved as a functional ligand for NKp30 in mammalian species separated by more than 100 million years of evolution. B7H6 and NKp30 are pseudogenes in laboratory mice. The rat thus represents an attractive experimental animal model to study the NKp30-B7H6 interaction in vivo. B7H6 was widely expressed among human cancer cell lines, and the expression level correlated strongly with the activation of human NKp30 reporter cells. Furthermore, siRNA knockdown of B7H6 abolished NKp30 reporter responses, suggesting that B7H6 is the major functionally relevant expressed ligand for NKp30 on these cancer cell lines."xsd:string
http://purl.uniprot.org/citations/30512185http://purl.org/dc/terms/identifier"doi:10.1002/eji.201847746"xsd:string
http://purl.uniprot.org/citations/30512185http://purl.uniprot.org/core/author"Dissen E."xsd:string
http://purl.uniprot.org/citations/30512185http://purl.uniprot.org/core/author"Dissen E."xsd:string
http://purl.uniprot.org/citations/30512185http://purl.uniprot.org/core/author"Daws M.R."xsd:string
http://purl.uniprot.org/citations/30512185http://purl.uniprot.org/core/author"Daws M.R."xsd:string
http://purl.uniprot.org/citations/30512185http://purl.uniprot.org/core/author"Saether P.C."xsd:string
http://purl.uniprot.org/citations/30512185http://purl.uniprot.org/core/author"Saether P.C."xsd:string
http://purl.uniprot.org/citations/30512185http://purl.uniprot.org/core/author"Hoelsbrekken S.E."xsd:string
http://purl.uniprot.org/citations/30512185http://purl.uniprot.org/core/author"Hoelsbrekken S.E."xsd:string
http://purl.uniprot.org/citations/30512185http://purl.uniprot.org/core/author"Bjornsen E.G."xsd:string
http://purl.uniprot.org/citations/30512185http://purl.uniprot.org/core/author"Bjornsen E.G."xsd:string
http://purl.uniprot.org/citations/30512185http://purl.uniprot.org/core/author"Boysen P."xsd:string
http://purl.uniprot.org/citations/30512185http://purl.uniprot.org/core/author"Boysen P."xsd:string
http://purl.uniprot.org/citations/30512185http://purl.uniprot.org/core/author"Henden C."xsd:string
http://purl.uniprot.org/citations/30512185http://purl.uniprot.org/core/author"Henden C."xsd:string
http://purl.uniprot.org/citations/30512185http://purl.uniprot.org/core/author"Thiruchelvam-Kyle L."xsd:string
http://purl.uniprot.org/citations/30512185http://purl.uniprot.org/core/author"Thiruchelvam-Kyle L."xsd:string
http://purl.uniprot.org/citations/30512185http://purl.uniprot.org/core/date"2018"xsd:gYear
http://purl.uniprot.org/citations/30512185http://purl.uniprot.org/core/date"2019"xsd:gYear
http://purl.uniprot.org/citations/30512185http://purl.uniprot.org/core/name"Eur. J. Immunol."xsd:string
http://purl.uniprot.org/citations/30512185http://purl.uniprot.org/core/name"Eur J Immunol"xsd:string
http://purl.uniprot.org/citations/30512185http://purl.uniprot.org/core/pages"54-65"xsd:string